Rituximab treatment for difficult-to-treat nephrotic syndrome in children: a multicenter, retrospective study

Date
2021
Author
Akgun, Cihangir
Akinci, Nurver
Yavuz, Sevgi
SAYGILI, Seha Kamil
TasdemIr, Mehmet
CANPOLAT, Nur
YILDIZ, NURDAN
Celakil, Mehtap
CANDAN, CENGİZ
Turkkan, Ozde Nisa
Ozkayin, Emine Nese
BIlge, Ilmay
SEVER, Fatma Lale
ALPAY, HARİKA
Tulpar, Sebahat
OzcelIk, Gul
Benzer, Meryem
Balat, Ayse
Goknar, Nilufer
Metadata
Show full item record
Abstract
Background/aim: This study aimed to evaluate the efficacy of rituximab in children with difficult-to-treat nephrotic syndrome, considering the type of disease (steroid-sensitive or -resistant) and the dosing regimen.
URI
http://hdl.handle.net/20.500.12627/173182
https://doi.org/10.3906/sag-2012-297
Collections